Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
ASH 2022 Primary Results of STIMULUS-MDS1: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of TIM-3 Inhibition With Sabatolimab Added to HMAs in Adult Patients With Higher-Risk MDS
By
ASH 2022 Conference Coverage
FEATURING
Amer Zeidan
By
ASH 2022 Conference Coverage
FEATURING
Amer Zeidan
135 views
December 21, 2022
Comments 0
Login to view comments.
Click here to Login